MBC BioLabs Announces New Partnership with Paul Hastings LLP

[San Francisco, CA – Feb 27, 2026] – MBC BioLabs is pleased to announce a new partnership with Paul Hastings LLP, strengthening our shared commitment to supporting high-growth biotech startups as they scale, innovate, and navigate an increasingly complex industry landscape.

Through this collaboration, MBC BioLabs resident companies will gain enhanced access to strategic legal counsel across the full lifecycle of company growth — from formation and early financing to capital markets transactions, strategic partnerships, regulatory navigation, and exit planning. Paul Hastings’ deep experience advising emerging growth companies and their investors will provide valuable guidance to founders operating in today’s dynamic life sciences market.

James Huie

Partner, Corporate Development

Matt Kovac

Of Counsel, Corporate Development

MBC BioLabs residents can connect with James Huie and Matt Kovac from Paul Hastings to discuss the partnership benefits in more detail.

About MBC BioLabs

At MBC BioLabs, we believe that startups are the greatest force for positive change in the world. We are dedicated to helping biotech startups succeed – we like to say that we enable awesome. We offer flexible and cost-effective lab space, complete with operational support and millions of dollars’ worth of state-of-the-art equipment and instrumentation, along with a vibrant community of like-minded individuals tackling the world’s biggest problems.

About Paul Hastings

Paul Hastings LLP partners with clients to understand and advise on their business and legal objectives, delivering tailored solutions, creative strategies, innovative value-add offerings and seamless service across practices and regions. Our lawyers handle intricate transactional, regulatory and litigation matters, providing guidance and insight into the industry as a whole.

We advise emerging growth companies with all aspects of their business activities from formation, initial start-up advice to exit transactions, as well as the investors who help power transformation into new markets and access to new technologies and opportunities. From startups to public offerings, our highly skilled team provides strategic counsel on nearly every type of capital markets offering.

Additionally, we guide clients through their R&D and commercialization collaborations, joint ventures and other strategic alliances, enabling them to efficiently grow, commercialize and diversify their product and service offerings to consumers. Our first-of-its-kind consulting group has significant experience working both independently and arm-in-arm with our top-tier legal colleagues to design, build, implement and operate effective compliance risk management programs—as well as the organizational constructs and resource models that support those programs across the enterprise. Whether the context in which we work together is reactive (i.e., an investigation or government action) or proactive (i.e., borne out of a desire to enhance your compliance program), Paul hastings has the experience necessary to tailor our approach to your everchanging, unique needs.

Learn more about Paul Hastings LLP: https://www.paulhastings.com/

Published On: February 27th, 2026Categories: MBC Biolabs News
Feel free to share!